Skip to main content
Back
Watch Compare

Tvardi Therapeutics, Inc.

TVRD
Nasdaq Manufacturing Chemicals
$2.90
▼ $0.06 (-2.03%)
Mkt Cap: 27.35 M
Price
$2.92
Mkt Cap
27.35 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Price History

Financial Trends

Analyst Price Target

6 analysts
Buy
Current
$2.90
+187.4%
Target
$8.33
$3.00
$8.00
$15.00
Forecast
Forward P/E -1.11
Forward EPS -$2.61
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$2.61
-$4.42 – -$0.56
 0.0 6
FY2026 -$2.22
-$2.96 – -$1.60
 0.0 6

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.57 -$0.78 -37.3%
Q32025 -$0.96 -$0.59 +38.7%
Q22025 -$0.39 $0.51 +230.8%
Q12025 -$0.59 -$0.50 +14.5%

ETFs Holding This Stock

IRSSX IRSSX
0.01% weight

No fundamental snapshot available yet.

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — 7.14 M 20.97 M 41.87 M 23.03 M
Net Income -18.21 M -70.87 M -118.51 M -85.47 M -88.44 M
EPS (Diluted) -3.26 -15.53 -2.19 -1.59 -1.74
Gross Profit — — — — —
Operating Income -26.75 M -58.38 M -121.50 M -87.54 M -89.08 M
EBITDA — — — — —
R&D Expenses 18.01 M 32.81 M 108.51 M 91.88 M 82.70 M
SG&A Expenses — — — — —
D&A 95,000.0 192,000.0 259,000.0 248,000.0 248,000.0
Interest Expense — — — — —
Income Tax 0.0 -398,000.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 32.07 M 43.83 M 125.84 M 182.24 M 247.06 M
Total Liabilities 11.13 M 48.42 M 68.76 M — —
Shareholders' Equity 20.95 M -4.59 M 57.09 M 158.78 M 227.52 M
Total Debt — — — — —
Cash & Equivalents 20.73 M 37.90 M 51.78 M 63.74 M 13.45 M
Current Assets 31.54 M 43.83 M 116.16 M 168.91 M 173.29 M
Current Liabilities 11.04 M 3.97 M 25.59 M 23.46 M 17.62 M